Detalles de la búsqueda
1.
Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab.
Ann Hematol
; 103(4): 1139-1147, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296903
2.
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.
Future Oncol
; 18(19): 2415-2431, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583358
3.
Endovascular Stroke Therapy Trends From 2011 to 2017 Show Significant Improvement in Clinical and Economic Outcomes.
Stroke
; 50(7): 1902-1906, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104618
4.
Duration of anticoagulant therapy and VTE recurrence in patients with cancer.
Support Care Cancer
; 27(10): 3833-3840, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734088
5.
The value of sPESI for risk stratification in patients with pulmonary embolism.
J Thromb Thrombolysis
; 48(1): 149-157, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729377
6.
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer.
Am J Hematol
; 93(5): 664-671, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396864
7.
Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal functionâ©.
Clin Nephrol
; 89(5): 314-329, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29231162
8.
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.
Int J Clin Pract
; 71(1)2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28097761
9.
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.
BMC Pulm Med
; 17(1): 37, 2017 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193193
10.
External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.
Thromb J
; 14: 7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26977136
11.
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.
J Thromb Thrombolysis
; 42(4): 513-9, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324143
12.
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications.
BMC Health Serv Res
; 16(1): 610, 2016 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770814
13.
The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.
Am J Hematol
; 94(2): E58-E61, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30474161
14.
Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.
BMC Health Serv Res
; 14: 80, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555428
15.
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".
Am J Hematol
; 93(9): E225-E227, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905381
16.
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma.
Oncol Ther
; 11(2): 263-275, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014590
17.
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States.
Oncol Ther
; 10(2): 411-420, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579821
18.
Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma.
EJHaem
; 3(1): 97-108, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846215
19.
Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE).
BMC Psychiatry
; 11: 168, 2011 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999370
20.
Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.
BMC Psychiatry
; 11: 167, 2011 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999346